β¨ Medicines Classification and PAYE Certificates
NEW ZEALAND GAZETTE
No. 54
Piperonyl butoxide
11-129-552 11-144-578 11-144-578 11-144-799
11-144-799 11-185-444 11-212-379 11-233-279
Polyoxylin
11-233-279 11-242-553 11-268-498 11-285-589
Potassium chloride; in medicines for oral rehydration therapy
11-285-589 11-323-618 11-342-124 11-445-586
Potassium guaiacolsulphonate
11-482-422 11-505-473 11-508-030 11-523-196
Promethazine theoclate; in a sealed container of not more than
12 tablets or capsules, labelled for the prevention of travel
sickness and sold at a transport terminal or aboard a ship or
plane
11-625-789 11-710-832 11-710-832 11-756-867
11-768-733 11-778-550 11-778-550 11-780-318
11-780-318 11-799-377 11-802-427 11-802-427
11-861-288 11-865-909 11-874-509 11-876-714
Pronase
11-916-325 12-017-669 12-021-658 12-062-567
12-185-200 12-202-121 12-509-200 12-510-116
Propyl undeccylenate
13-018-782 13-204-354 13-120-765 13-139-563
Pumilio pine oil
13-178-569 13-184-720 13-210-624 13-217-254
Pyrethrins I and II
13-318-451 13-349-691 13-375-208 13-385-629
13-385-629 13-390-584 13-402-914 13-415-420
Quaternary ammonium antiseptic compounds
13-427-445 13-430-446 13-433-593 13-460-205
Quinine; and its salts; in medicines containing 50 mg or less of
quinine per recommended daily dose
13-510-229 13-510-229 13-510-229 13-523-282
13-533-733 13-547-378 13-560-390 13-591-393
Salicylic acid; and its salts; in medicines for external use
containing 12.5% or less of salicylic acid
13-598-959 13-684-944 13-706-018 13-736-588
13-747-458 13-747-458 13-747-458 13-748-675
13-754-365 13-787-050 13-787-050 13-787-050
Senegal
13-901-163 13-924-724 13-928-703 13-960-348
Sodium bitartrate
13-994-714 14-006-583 14-013-024 14-046-607
Sodium dichloro-isocyanurate
14-055-762 14-191-550 14-416-412 14-448-829
Sodium lauryl sulphoacetate
14-560-882 14-738-698 14-839-089 14-856-900
Sodium sulphide
14-856-900 14-856-900 15-223-715 15-248-815
15-712-295 15-736-801 15-872-985 15-905-832
Strontium chloride
16-075-930 16-192-521 16-299-081 16-321-850
16-322-924 16-469-052 16-469-052 16-843-644
Subtilisin A
17-045-652 17-195-104 17-195-269 17-282-146
Sulphurated potash
17-369-709 17-671-324 17-671-324 18-196-387
Tar; in medicines containing 5% or less of tar
18-604-973 18-648-270 18-799-480 18-799-480
19-148-017 19-517-187 20-150-947 20-243-554
Terpin hydrate
20-348-166 20-364-270 20-368-071 20-438-274
Thuryl salicylate
20-438-274 20-438-975 20-493-763 20-691-506
Toliclate
20-714-140 20-766-617 20-775-491 20-830-832
Tolnaftate
20-901-721 21-083-135 21-177-016 21-187-836
21-209-368 21-209-368 21-209-368 21-274-194
Triclosan
21-356-883 21-499-676 21-506-826 21-506-826
Trypsin
21-563-013 21-563-013 21-563-013 21-577-154
21-577-154 21-577-154 21-604-216 21-604-216
Tyloxapol
21-613-541 21-833-355 21-839-716 21-915-319
Undecenoic acid; and its salts and esters
21-915-319 21-983-234 22-065-564 22-159-917
22-224-700 22-285-725 22-513-513 22-766-667
Xylometazoline; and its salts; for nasal use when sold at an
airport
23-042-045 23-166-968 23-221-233 23-335-573
Zinc; and its salts; in medicines for internal use containing
25 mg or less of elemental zinc per recommended daily dose
23-660-458 23-863-197 24-016-943 24-293-467
24-351-467 24-389-308 24-424-332 24-424-847
24-424-847 24-440-133 24-530-663 24-565-084
Dated this 13th day of April 1993.
MAURICE WILLIAMSON, Associated Minister of Health
gc3126
Inland Revenue
Interest PAYE Cancelled Certificate of Exemption Numbers
for the Year Ended 31 March 1993:
10-025-281 10-069-777 10-084-466 10-084-466
10-097-177 10-100-542 10-106-079 10-133-602
10-138-043 10-140-110 10-140-110 10-147-146
10-175-240 10-196-116 10-231-264 10-243-300
10-243-300 10-255-589 10-255-589 10-262-852
10-288-231 10-305-179 10-305-179 10-309-956
10-309-956 10-375-169 10-381-075 10-381-075
10-405-173 10-425-255 10-456-487 10-467-772
10-467-772 10-470-652 10-490-952 10-523-036
10-596-610 10-599-377 10-608-406 10-610-117
10-628-628 10-658-225 10-658-225 10-695-449
10-700-337 10-722-508 10-803-918 10-845-467
10-845-467 10-884-772 10-937-124 10-947-359
10-947-359 10-967-678 11-033-873 11-033-873
11-038-425 11-038-425 11-038-425 11-067-026
11-095-224 11-112-390 11-112-390 11-113-801
24-571-769 24-579-441 24-579-441 24-580-075
24-580-075 24-598-136 24-605-027 24-605-027
24-606-902 24-610-233 24-618-528 24-618-528
24-618-528 24-620-328 24-660-265 24-660-265
24-697-347 24-700-089 24-710-270 24-752-747
24-778-843 24-788-709 24-796-544 24-809-706
24-824-435 24-830-713 24-830-721 24-848-868
24-862-712 25-004-973 25-012-815 25-201-159
25-201-159 25-202-661 25-202-661 25-238-949
25-394-208 25-394-208 25-394-208 25-394-852
25-420-381 25-420-381 25-424-443 25-450-922
25-450-922 25-501-829 25-501-829 25-505-484
25-505-484 25-552-305 25-552-305 25-736-990
25-736-990 25-763-990 25-763-122 25-763-122
25-763-173 25-812-050 26-036-461 26-077-966
26-077-966 26-077-966 26-077-968 26-101-018
26-101-138 26-119-138 26-119-446 26-121-035
26-127-769 26-137-436 26-138-515 26-189-985
26-189-985 26-357-683 26-809-827 26-809-835
27-505-591 27-876-765 27-876-765 27-951-538
27-970-117 27-997-058 28-052-391 28-178-395
28-260-385 28-282-949 28-282-949 28-283-896
28-323-530 28-368-011 28-435-762 28-435-762
28-495-633 28-495-633 28-538-472 28-650-426
Next Page →
PDF embedding disabled (Crown copyright)
View this page online at:
VUW Te Waharoa —
NZ Gazette 1993, No 54
NZLII —
NZ Gazette 1993, No 54
β¨ LLM interpretation of page content
π₯
Classification of Medicines under the Medicines Act 1981
(continued from previous page)
π₯ Health & Social Welfare13 April 1993
Medicines Act 1981, Prescription Medicines, Restricted Medicines, Pharmacy-only Medicines, General Sale Medicines
- MAURICE WILLIAMSON, Associated Minister of Health
π° Interest PAYE Cancelled Certificate of Exemption Numbers for the Year Ended 31 March 1993
π° Finance & RevenuePAYE, Certificate of Exemption, Inland Revenue, Taxation